Correlation Between Posterior Crossbite and Risk of Obstructive Sleep Apnea

April 25, 2026 updated by: Marwa Ahmed Salmoon, October University for Modern Sciences and Arts

Correlation Between Posterior Crossbite and Risk of Obstructive Sleep Apnea: A Questionnaire-Based Analysis

Correlation Between Posterior Crossbite and Risk of Obstructive Sleep Apnea

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Understanding the correlation between posterior crossbite and OSA risk is essential for early detection and prevention. Pediatric dentists and orthodontists are uniquely positioned to identify craniofacial risk factors and initiate early intervention.

Screening tools such as OSA-18 can help identify children at risk and facilitate timely referral for multidisciplinary management. Furthermore, evaluating this association will contribute to improving clinical decision-making and patient outcomes.

Aim of study:

To assess the correlation between posterior crossbite and the risk of obstructive sleep apnea in children using the OSA-18 questionnaire.

Study Type

Observational

Enrollment (Estimated)

420

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Children with posterior crossbite Patients without posterior crossbite, or Normative OSA-18 scores / low-risk groups

Description

Inclusion Criteria:

  • Children in mixed dentition stage aged 6-12 years
  • Presence of posterior crossbite

Exclusion Criteria:

  • Syndromic patients
  • Previous orthodontic treatment
  • Chronic respiratory or neurological disorders Matching criteria and allocation ratio

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
intervention
Screening using the OSA-18 (Obstructive Sleep Apnea-18) questionnaire
Screening using the OSA-18 (Obstructive Sleep Apnea-18) questionnaire
comparator
Patients without posterior crossbite, or Normative OSA-18 scores / low-risk groups
Patients without posterior crossbite, or Normative OSA-18 scores / low-risk groups

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk or presence of obstructive sleep apnea (OSA) based on OSA-18 scores
Time Frame: 2 months
questionnaire
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sally M Mosallam, Master Degree, MSA University
  • Principal Investigator: Ahmed Ayman, MSA University
  • Principal Investigator: Mohamed Hesham, MSA University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

April 25, 2026

First Submitted That Met QC Criteria

April 25, 2026

First Posted (Actual)

May 1, 2026

Study Record Updates

Last Update Posted (Actual)

May 1, 2026

Last Update Submitted That Met QC Criteria

April 25, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Crossbite Teeth

Clinical Trials on Interventions

Subscribe